Tormod K. Guren
Oslo, 0424, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity.
Journal: Cell reports. Medicine
Published: December 11, 2025
Pembrolizumab in advanced malignant peripheral nerve sheath tumors: a single-arm phase 2 trial.
Journal: NPJ precision oncology
Published: July 02, 2025
Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival.
Journal: Oncoimmunology
Published: December 20, 2024
Early-onset colorectal cancer incidence in Norway: a national registry-based study (1993-2022) analyzing subsite and morphology trends.
Journal: ESMO gastrointestinal oncology
Published: August 02, 2024
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 02, 2024
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Journal: Nature medicine
Published: October 18, 2023
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.
Journal: EBioMedicine
Published: April 22, 2023
Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS-/BRAF-Mutated Metastatic Colorectal Cancer.
Journal: Clinical colorectal cancer
Published: March 11, 2023
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination.
Journal: Journal of translational medicine
Published: August 10, 2022
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.
Journal: Journal of translational medicine
Published: July 15, 2022
A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer.
Journal: ESMO open
Published: May 19, 2022
Last Updated: 09/26/2026